Literature DB >> 6731806

Resolution of some glycopeptides of hen ovalbumin by reverse-phase high-pressure liquid chromatography.

V K Dua, C A Bush.   

Abstract

Reverse-phase high-pressure liquid chromatography has been shown to be useful in fractionation of oligosaccharides containing N-acetyl amino sugars on the basis of stereochemical differences. Data in this paper show this same stereochemical selectivity can be obtained for glycopeptides. Using dilute aqueous phosphate for elution, three major high-mannose glycopeptides from ovalbumin can be separated on the analytical scale in a few minutes and the same method can also be used for preparation of the glycopeptides on the milligram scale. High-field proton NMR spectroscopy is used to identify two of the compounds as the mannose-5 and -6 glycopeptides (E3 and D3) and the third as the mannose-6 glycopeptide substituted by two N-acetyl glucosamine (GlcNAc) residues (C3B). The NMR spectra and analytical chromatograms of the glycopeptides show high purity and freedom from contaminants previously identified in ovalbumin glycopeptides.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6731806     DOI: 10.1016/0003-2697(84)90342-7

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  3 in total

1.  Separation of positional isomers of oligosaccharides and glycopeptides by high-performance anion-exchange chromatography with pulsed amperometric detection.

Authors:  M R Hardy; R R Townsend
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  Structural assessment of the N-linked oligosaccharides of cell-CAM 105 by lectin-agarose affinity chromatography.

Authors:  M F Bierhuizen; M Hansson; P Odin; H Debray; B Obrink; W van Dijk
Journal:  Glycoconj J       Date:  1989       Impact factor: 2.916

Review 3.  N- and O-linked oligosaccharides of allergenic glycoproteins.

Authors:  K Fötisch; S Vieths
Journal:  Glycoconj J       Date:  2001-05       Impact factor: 2.916

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.